Tenon Medical, Inc. (TNON)
| Market Cap | 41.05M |
| Revenue (ttm) | 159,800 |
| Net Income (ttm) | -7.05M |
| Shares Out | 11.76M |
| EPS (ttm) | -0.60 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,767,318 |
| Open | 3.01 |
| Previous Close | 3.00 |
| Day's Range | 3.01 - 4.37 |
| 52-Week Range | 2.89 - 59.89 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About TNON
Tenon Medical, a medical device company formed in 2012, has developed a proprietary, U.S. Food and Drug Administration cleared surgical implant system, which is designed to optimize sacroiliac joint (“SI-Joint”) fixation / fusion surgery and corresponding outcomes. The CATAMARAN System is a singular implant designed with several proprietary components which allow for it to be explicitly formatted to address the SI Joint with a single approach and implant. We refer to this as the “One and Done” feature of the implant. Tenon also has deve...
Financial Performance
In 2021, Tenon Medical's revenue was $159,800, an increase of 264.67% compared to the previous year's $43,820. Losses were -$7.05 million, 1,104.5% more than in 2020.
Financial StatementsNews
Top Penny Stocks to Buy Now? 3 to Watch in June 2022
Can these penny stocks make gains next month? The post Top Penny Stocks to Buy Now?